ORBi: Detailled Reference

Article (Scientific journals)

Letter to the Editor: Should We Really Take Anti-Viral Therapy into Account in Chronic Hepatitis B Patients with Normal Liver Function?

Khosravi, Mohammad Hossein; Alavian, Seyed Moayed

2016 • In Journal of Korean Medical Science, 31 (5), p. 824

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/291130

DOI
10.3346/jkms.2016.31.5.824

PubMed
27134509

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

jkms-31-824.pdf

Author postprint (166.83 kB)

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Aminotransferase; Antiviral Therapy; Chronic Hepatitis B; Liver Neoplasms; Treatment; Viruses; Antiviral Agents; Antiviral Agents/therapeutic use; Hepatitis B virus; Hepatitis B, Chronic/drug therapy; Humans; General Medicine

Disciplines :

Gastroenterology & hepatology

Author, co-author :

Khosravi, Mohammad Hossein ; Université de Liège - ULiège ; Students' Research Committee, Baqiyatallah University of Medical Sciences, Tehran, IR Iran., Middle East Liver Diseases Center (MELD), Tehran, IR Iran

Alavian, Seyed Moayed ; Middle East Liver Diseases Center (MELD), Tehran, IR Iran

Language :

English

Title :

Letter to the Editor: Should We Really Take Anti-Viral Therapy into Account in Chronic Hepatitis B Patients with Normal Liver Function?

Publication date :

May 2016

Journal title :

Journal of Korean Medical Science

ISSN :

1011-8934

eISSN :

1598-6357

Publisher :

Korean Academy of Medical Sciences, Korea south

Volume :

31

Issue :

5

Pages :

824

Peer reviewed :

Peer Reviewed verified by ORBi

Additional URL :

http://synapse.koreamed.org/pdf/10.3346/jkms.2016.31.5.824

Available on ORBi :

since 21 May 2022

Statistics

Number of views

47 (0 by ULiège)

Number of downloads

14 (0 by ULiège)

More statistics

Scopus citations^®

0

Scopus citations^®
without self-citations

0

OpenCitations

0

OpenAlex citations

0

Bibliography

Lee J, Sinn DH, Kim JH, Gwak GY, Kim HS, Jung SH, Paik YH, Choi MS, Lee JH, Koh KC, et al. Hepatocellular carcinoma risk of compensated cirrhosis patients with elevated HBV DNA levels according to serum aminotransferase levels. J Korean Med Sci 2015; 30: 1618-24.
Hung IF, Poon RT, Lai CL, Fung J, Fan ST, Yuen MF. Recurrence of hepatitis B-related hepatocellular carcinoma is associated with high viral load at the time of resection. Am K Gastroenterol 2008; 103: 1663-73.
Vanni E, Bugianesi E. Obesity and liver cancer. Clinics Liver Dis 2014; 18: 191-203.
Keshvari M, Alavian SM, Sharafi H. How can we make decision for patients with chronic hepatitis B according to hepatitis B virus (HBV) DNA level? Hepat Mon 2014; 14: e15285.
Cho JY, Paik YH, Sohn W, Cho HC, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease. Gut 2014; 63: 1943-50.
Sali S, Sharafi H, Alavian SH, Alavian SM, Etesam F, Salimi S, Merza MA, Keshvari M. Can serum level of HBsAg differentiate HBeAg-negative chronic hepatitis B from inactive carrier state? Diagn Microbiol Infect Dis 2015; 82: 114-9.

Similar publications